Cuorips Inc. (4894.T)
JPY 4585.0
(-4.18%)
JPY 4585.0
(-4.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -588.48 Million JPY | -30.65% |
| 2022 | -450.43 Million JPY | -20.67% |
| 2021 | -373.26 Million JPY | -32.44% |
| 2020 | -281.84 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -195.31 Million JPY | -53.56% |
| 2023 FY | -588.48 Million JPY | -30.65% |
| 2023 Q4 | -127.19 Million JPY | 25.68% |
| 2023 Q3 | -171.14 Million JPY | -9.4% |
| 2023 Q1 | -133.72 Million JPY | -41.98% |
| 2023 Q2 | -156.43 Million JPY | -16.98% |
| 2022 FY | -450.43 Million JPY | -20.67% |
| 2022 Q4 | -94.18 Million JPY | 0.0% |
| 2021 FY | -373.26 Million JPY | -32.44% |
| 2020 FY | -281.84 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 198.603% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -18.439% |
| GNI Group Ltd. | 13.1 Billion JPY | 104.489% |
| Linical Co., Ltd. | 725.72 Million JPY | 181.09% |
| Trans Genic Inc. | 89.43 Million JPY | 757.998% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 58.73% |
| Soiken Holdings Inc. | -610 Million JPY | 3.528% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | 23.844% |
| AnGes, Inc. | -11.96 Billion JPY | 95.083% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 47.494% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 93.822% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 664.231% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 31.921% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 47.314% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 53.369% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 26.306% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -74.436% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 51.17% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 55.938% |
| PeptiDream Inc. | 6.77 Billion JPY | 108.689% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 69.508% |
| Ribomic Inc. | -1.11 Billion JPY | 47.277% |
| SanBio Company Limited | -4.53 Billion JPY | 87.035% |
| Healios K.K. | -3.37 Billion JPY | 82.584% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 49.052% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 57.769% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 58.055% |
| StemRIM | -2.07 Billion JPY | 71.653% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 148.177% |
| FunPep Company Limited | -994 Million JPY | 40.796% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 33.786% |
| Stella Pharma Corporation | -760.3 Million JPY | 22.598% |
| TMS Co., Ltd. | -943.25 Million JPY | 37.611% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 24.104% |
| K Pharma,Inc. | 366.05 Million JPY | 260.764% |
| Takara Bio Inc. | 3 Billion JPY | 119.597% |
| ReproCELL Incorporated | -409.29 Million JPY | -43.781% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 5419.416% |
| StemCell Institute Inc. | 413.75 Million JPY | 242.229% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 507.238% |
| CellSeed Inc. | -697.77 Million JPY | 15.662% |